SequelSEC

QHSLab, Inc. USAQ

Surgical & Medical Instruments & Apparatus · CIK 0000856984 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$2.69M
Fiscal year ended 2025-12-31
Operating income
$131.24K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

QHSLab, Inc. (USAQ) reported revenue of $2.69M and net income of -$457.42K for the fiscal year ended 2025-12-31. This page shows 8 annual periods of income statement, balance sheet and cash flow figures normalized from QHSLab, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

QHSLab, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312015-12-312014-12-31
Revenue$2.69M$2.13M$1.41M$1.24M$1.41M$124.53K$0$0
Cost of revenue$880.89K$774.04K$615.39K$623.67K$743.67K$74.44KUnavailableUnavailable
Gross profit$1.81M$1.36M$793.61K$619.52K$670.75K$50.09KUnavailableUnavailable
Operating income$131.24K$205.74K-$240.16K-$560.54K-$502.26K-$275.10K-$722.11KUnavailable
Net income-$457.42K-$259.24K-$468.36K-$996.00K-$770.18K-$327.39K-$722.11K-$40.48K
Research & development$484.87K$294.48K$214.01K$190.12K$90.87K$98.29KUnavailableUnavailable
Weighted-average diluted sharesshares 19.34Mshares 10.29Mshares 9.42Mshares 9.00MUnavailableUnavailableUnavailableUnavailable
Pretax income$457.42K-$259.24K-$468.36K-$996.00K-$770.18K-$327.39KUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailable$0UnavailableUnavailableUnavailableUnavailable
Diluted EPS$0.02$-0.03$-0.05$-0.11UnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$1.12M$785.56K$747.64K$917.83K$1.05M$226.91KUnavailableUnavailable
General & administrative$439.14K$276.50K$259.11K$387.51K$454.01K$131.77K$38.14K$28.92K
Selling & marketing$683.48K$509.06K$488.54K$530.32K$592.07K$95.14KUnavailableUnavailable

Balance

QHSLab, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312015-12-312014-12-31
Cash & equivalents$636.16K$157.17K$51.58K$178.69K$286.86K$94.34KUnavailableUnavailable
Total assets$2.17M$1.80M$1.68M$1.96M$2.21M$297.86K$0$0
Current assets$883.01K$420.83K$156.13K$285.58K$445.78K$266.16K$0$0
Total liabilities$546.08K$2.41M$2.06M$1.88M$1.38M$906.19K$460.28K$413.17K
Current liabilities$449.86K$2.41M$2.06M$1.71M$874.95K$214.62K$131.10K$413.17K
Total equity incl. NCI$1.62M-$607.76K-$375.62K$76.24K$824.07K-$608.33K-$460.28K-$413.17K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$35.79K$41.78K$25.18K$51.84K$65.74K$99.70KUnavailableUnavailable
Accounts receivable$190.61K$196.09K$71.38K$47.73K$70.47K$60.52KUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt$90.70KUnavailableUnavailableUnavailableUnavailableUnavailable$329.18KUnavailable
Accounts payable$326.43K$340.96K$78.91K$85.74K$20.37K$145.42KUnavailableUnavailable

Cash flow

QHSLab, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312015-12-312014-12-31
Operating cash flow-$178.12K$142.44K-$159.63K-$350.99K-$354.74K-$165.56K-$38.04K-$18.38K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailable-$37.12K-$154.57K-$31.70KUnavailable$0
Financing cash flow$300.87K-$36.85K$32.52K$279.95K$701.82K$268.02K$38.04K$18.38K
Net change in cash$478.99K$105.59K-$127.11K-$108.16K$192.51K$70.75KUnavailable$0
Stock-based compensation$0$0$6.00K$30.08K$35.68K$7.08KUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$90.73K$146.58K$146.58K$127.96K$36.06K$0UnavailableUnavailable

Derived

QHSLab, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312015-12-312014-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin67.3%63.7%56.3%49.8%47.4%40.2%UnavailableUnavailable
Operating margin4.9%9.7%-17.0%-45.1%-35.5%-220.9%UnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue0.0%0.0%0.4%2.4%2.5%5.7%UnavailableUnavailable
Current ratio1.96x0.17x0.08x0.17x0.51x1.24xUnavailable0.00x
Revenue YoY growth26.3%51.3%13.3%-12.1%1035.8%UnavailableUnavailableUnavailable
Net marginUnavailable-12.2%-33.2%-80.1%-54.5%-262.9%UnavailableUnavailable
R&D / revenue18.0%13.8%15.2%15.3%6.4%78.9%UnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.06xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USAQ in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.